GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID ▲ | Title | Descriptor |
---|---|---|---|
6B6P | P00760 | Orthorhombic trypsin cryocooled to 100 K with 30% xylose as cryoprotectant | Cationic trypsin (E.C.3.4.21.4) |
6DZF | P00760 | Orthorhombic trypsin cryocooled to 100 K with 20% xylose as cryoprotectant | |
6B6O | P00760 | Orthorhombic trypsin cryocooled to 100 K with 20% xylose as cryoprotectant | Cationic trypsin (E.C.3.4.21.4) |
6AVL | P00760 | Orthorhombic Trypsin (295 K) in the presence of 50% xylose | Cationic trypsin (E.C.3.4.21.4) |
6B6Q | P00760 | Orthorhombic trypsin cryocooled to 100 K with 50% xylose as cryoprotectant | Cationic trypsin (E.C.3.4.21.4) |
1Z7K | P00761 | Crystal Structure of Trypsin- Ovomucoid turkey egg white inhibitor complex | |
5V8V | P00797 | Crystal Structure of Human Renin in Complex with a biphenylpipderidinylcarbinol | |
5TMG | P00797 | Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor | Renin (E.C.3.4.23.15) |
5TMK | P00797 | Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor | Renin (E.C.3.4.23.15) |
5SXN | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | Renin (E.C.3.4.23.15) |
5SY2 | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | Renin (E.C.3.4.23.15) |
5SY3 | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | Renin (E.C.3.4.23.15) |
5SZ9 | P00797 | Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors | Renin (E.C.3.4.23.15) |
5T4S | P00797 | Novel Approach of Fragment-Based Lead Discovery applied to Renin Inhibitors | Renin (E.C.3.4.23.15) |
5VPM | P00797 | Crystal Structure of Human Renin in Complex with a biphenylpipderidinylcarbinol | Renin (E.C.3.4.23.15) |
5VRP | P00797 | Crystal Structure of Human Renin in Complex with a biphenylpipderidinylcarbinol | Renin (E.C.3.4.23.15) |
6I3F | P00797 | Crystal structure of the complex of human angiotensinogen and renin at 2.55 Angstrom | |
1HRN | P00797 | HIGH RESOLUTION CRYSTAL STRUCTURES OF RECOMBINANT HUMAN RENIN IN COMPLEX WITH POLYHYDROXYMONOAMIDE INHIBITORS | RENIN COMPLEXED WITH POLYHYDROXYMONOAMIDE INHIBITOR BILA 980 |
1RNE | P00797 | THE CRYSTAL STRUCTURE OF RECOMBINANT GLYCOSYLATED HUMAN RENIN ALONE AND IN COMPLEX WITH A TRANSITION STATE ANALOG INHIBITOR | RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.C.3.4.23.15) COMPLEX WITH CGP 38'560 |
2G1N | P00797 | Ketopiperazine-based renin inhibitors: Optimization of the "C" ring | Renin (E.C.3.4.23.15) |
2G1O | P00797 | Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring | Renin (E.C.3.4.23.15) |
2G1R | P00797 | Ketopiperazine-Based Renin Inhibitors: Optimization of the C Ring | Renin (E.C.3.4.23.15) |
2G1S | P00797 | Ketopiperazine-Based Renin Inhibitors: Optimization of the C Ring | Renin (E.C.3.4.23.15) |
2G1Y | P00797 | Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring | Renin (E.C.3.4.23.15) |
2G22 | P00797 | Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring | Renin (E.C.3.4.23.15) |
2REN | P00797 | STRUCTURE OF RECOMBINANT HUMAN RENIN, A TARGET FOR CARDIOVASCULAR-ACTIVE DRUGS, AT 2.5 ANGSTROMS RESOLUTION | RENIN (E.C.3.4.23.15) |
2V0Z | P00797 | Crystal Structure of Renin with Inhibitor 10 (Aliskiren) | RENIN (E.C.3.4.23.15) |
3G6Z | P00797 | Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors | Renin (E.C.3.4.23.15) |
3G70 | P00797 | Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors | Renin (E.C.3.4.23.15) |
3G72 | P00797 | Design and Preparation of Potent, Non-Peptidic, Bioavailable Renin Inhibitors | Renin (E.C.3.4.23.15) |
3GW5 | P00797 | Crystal structure of human renin complexed with a novel inhibitor | |
3K1W | P00797 | New Classes of Potent and Bioavailable Human Renin Inhibitors | Renin (E.C.3.4.23.15) |
3KM4 | P00797 | Optimization of Orally Bioavailable Alkyl Amine Renin Inhibitors | |
3O9L | P00797 | Design and optimisation of new piperidines as renin inhibitors | Renin (E.C.3.4.23.15), Renin (E.C.3.4.23.15) |
3OAD | P00797 | Design and optimization of new piperidines as renin inhibitors | Renin (E.C.3.4.23.15) |
3OAG | P00797 | Design and optimization of new piperidines as renin inhibitors | Renin (E.C.3.4.23.15) |
3OOT | P00797 | Crystal Structure Analysis of Renin-indole-piperazin inhibitor complexes | Renin (E.C.3.4.23.15) |
3OQF | P00797 | Crystal Structure Analysis of Renin-indole-piperazine inhibitor complexes | Renin (E.C.3.4.23.15) |
3OQK | P00797 | Crystal Structure Analysis of Renin-indole-piperazin inhibitor complexes | Renin (E.C.3.4.23.15) |
3Q3T | P00797 | Alkyl Amine Renin Inhibitors: Filling S1 from S3 | |
3Q4B | P00797 | Clinically Useful Alkyl Amine Renin Inhibitors | |
3Q5H | P00797 | Clinically Useful Alkyl Amine Renin Inhibitors | |
3SFC | P00797 | Structure-Based Optimization of Potent 4- and 6-Azaindole-3-Carboxamides as Renin Inhibitors | Renin (E.C.3.4.23.15) |
3VCM | P00797 | Crystal structure of human prorenin | |
3VSW | P00797 | Human renin in complex with compound 8 | |
3VSX | P00797 | Human renin in complex with compound 18 | |
3VUC | P00797 | Human renin in complex with compound 5 | |
3VYD | P00797 | Human renin in complex with inhibitor 6 | |
3VYE | P00797 | Human renin in complex with inhibitor 7 | |
3VYF | P00797 | Human renin in complex with inhibitor 9 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024